Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/ijerph18126497 http://scihub22266oqcxt.onion/10.3390/ijerph18126497 34208607!8296394!34208607     free     free     free       Int+J+Environ+Res+Public+Health 2021 ; 18 (12): ä Nephropedia Template TP {{tp|p=34208607|t=2021. Serology in COVID-19: Comparison of Two Methods |pdf=|usr=}}{{34208607}} gab.com Text Serology in COVID-19: Comparison of Two Methods JO: Int J Environ Res Public Health http://www.kidney.de/pget.php?&tw=1&pmid=34208607 #FOAvip BACKGROUND: The aim of our study was to examine the performance of two assays in detecting SARS-CoV-2 antibodies. METHODS: A total of 127 COVID-19 disease contacts from the Infectious Diseases Department were included. Two serological tests were used: SARS-CoV-2 IgG CMIA on the Alinity system (Abbott) and LIAISON((R)) SARS-CoV-2 S1/S2 IgG CLIA (DiaSorin). RESULTS: The assays exhibited a 96.85% (123/127 patients) test result agreement. In two cases, the positive results obtained by SARS-CoV-2 IgG CMIA on the Alinity system (Abbott) were negative based on the LIAISON((R)) SARS-CoV-2 S1/S2 IgG CLIA (DiaSorin) test, and in two cases, negative results from the LIAISON((R)) SARS-CoV-2 S1/S2 IgG CLIA (DiaSorin) test were positive with the SARS-CoV-2 IgG CMIA on the Alinity system (Abbott). CONCLUSIONS: Based on the results of our study, we conclude that in population medicine, the assessments of anti-SARS-CoV-2 antibodies after exposure to SARS-CoV-2 virus based on spike protein or nucleocapsid protein show comparable effectiveness. Twit Text FOAVip Serology in COVID-19: Comparison of Two Methods ????Int J Environ Res Public Health http://www.kidney.de/pget.php?&tw=1&pmid=34208607 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34208607 #FOAvip English Wikipedia <ref>{{Cite pmid|34208607}}</ref> Serology in COVID-19: Comparison of Two Methods #MMPMID34208607 Moniuszko-Malinowska A; Jelski W; Dunaj J; Mroczko B; Czupryna P; Kruszewska E; Pancewicz S Int J Environ Res Public Health 2021[Jun]; 18 (12): ä PMID34208607show ga BACKGROUND: The aim of our study was to examine the performance of two assays in detecting SARS-CoV-2 antibodies. METHODS: A total of 127 COVID-19 disease contacts from the Infectious Diseases Department were included. Two serological tests were used: SARS-CoV-2 IgG CMIA on the Alinity system (Abbott) and LIAISON((R)) SARS-CoV-2 S1/S2 IgG CLIA (DiaSorin). RESULTS: The assays exhibited a 96.85% (123/127 patients) test result agreement. In two cases, the positive results obtained by SARS-CoV-2 IgG CMIA on the Alinity system (Abbott) were negative based on the LIAISON((R)) SARS-CoV-2 S1/S2 IgG CLIA (DiaSorin) test, and in two cases, negative results from the LIAISON((R)) SARS-CoV-2 S1/S2 IgG CLIA (DiaSorin) test were positive with the SARS-CoV-2 IgG CMIA on the Alinity system (Abbott). CONCLUSIONS: Based on the results of our study, we conclude that in population medicine, the assessments of anti-SARS-CoV-2 antibodies after exposure to SARS-CoV-2 virus based on spike protein or nucleocapsid protein show comparable effectiveness. |*COVID-19[MESH] |Antibodies, Viral[MESH] |Humans[MESH] |Immunoassay[MESH] |SARS-CoV-2[MESH]Serology in COVID-19: Comparison of Two Methods (epmc).pdf DeepDyve Pubget Overpricing